Myriad Genetics, Inc. (MYGN)
Q1 2012 Earnings Call
May 1, 2012 4:30 pm ET
Rebecca Chambers – Director of Investor Relations
Peter D. Meldrum – President and Chief Executive Officer
Mark C. Capone – President, Myriad Genetic Laboratories
James S. Evans – Chief Financial Officer and Treasurer
Scott Gleason – Stephens Inc.
John Wood – Jefferies & Company, Inc
Amanda Murphy – William Blair & Company, L.L.C.
Michael Yee – RBC Capital Markets
William T. Cook – Piper Jaffray, Inc.
Doug Schenkel – Cowen and Co.
Tycho W. Peterson – JPMorgan Securities LLC
David Ferreiro – Oppenheimer Securities
Isaac Ro – Goldman Sachs
Kevin DeGeeter – Ladenburg Thalmann Securities
Ladies and gentlemen, thank you for standing by. Welcome to the Myriad Genetics 2012 Third Quarter Earnings Call. During the presentation, all participants will be in a listen-only mode. Afterwards we’ll conduct a question-and-answer session. (Operator Instructions) As a reminder, this conference is being recorded Tuesday, May 1, 2012.
I would now like to turn the conference over to Ms. Rebecca Chambers, Director of Investor Relations. Please go ahead.
Good afternoon everyone, and welcome to the Myriad Genetics’ Third Fiscal Quarter Earnings Call. During the call, we will review the financial results we released today and the progress made this quarter on our strategic directives, after which we will host a question-and-answer session. If you have not had a chance to review the earnings release it can be found in the Investor Relations section of our website at myriad.com.